Gastrointestinal and sensory manifestations, nutrition management, and energy‐protein intake in hospitalized patients with COVID‐19

• Published in: Nutrition in clinical practice 2022-10, Vol.37 (5), p.1152-1161
• Main Authors: Torrinhas, Raquel Susana, Ribeiro, Paulo César, Syagha, Yassmin, Coradelli, Anna Carolina Pompermayer, Miguel, Bianca Zanchetta Buani, Freire, Thaís Nunes, Silva, Marli Alves Ramelho, Ruotolo, Fabiana, Almeida, Daniela Hummel, Buzato, Janayna Nayara, e Silva, Henrique Oliveira, Martinez, Ana Cristina, Dias, Maria Carolina Gonçalves, Waitzberg, Dan Linetzky
• Format: Article
• Language: English
• Subjects: anorexia; Clinical Research; COVID‐19; gastrointestinal symptoms; nutrition therapy; oral nutrition supplement
• ISSN: 0884-5336; 1941-2452
• DOI: 10.1002/ncp.10906

Background Gastrointestinal and sensory manifestations (GSMs) of coronavirus disease 2019 (COVID‐19) may affect food intake, resulting in malnutrition and poor outcomes. We characterized the impact of GSMs and oral nutrition supplementation on energy‐protein intake (EPI) and hospital discharge in adult patients with COVID‐19. Methods Patients from two hospitals were enrolled (n = 357). We recorded the presence and type of GSM at admission, estimated energy requirements (EER) and the EPI based on regular food intake (plate diagram sheets) during hospital stays. Patients not achieving 60% of their EER from food over 2 consecutive days received oral nutrition supplementation (ONS) with a high‐energy‐protein oral drink. Results Most patients (63.6%) presented with GSMs at admission. Anorexia was the most common manifestation (44%). Patients with anorexia or more than one GSMs were more likely to not achieve 60% EER on the first day of follow‐up and to require the ONS intervention (P ≤ 0.050). Prevalence of at least one GSM was higher in patients who did not achieve hospital discharge than in patients who achieved it (74.2% vs 54.6%, P = 0.038). The patients requiring ONS (26.9%) demonstrated good adherence to the intervention (79.3%), achieved their EER during 95.7% of the supplementation time, and presented with hospital discharge rates similar to patients not requiring ONS (92.2% vs 91.9%, respectively; P = 1.000). Conclusions GSM were prevalent in COVID‐19 and it impaired EER attendance and patient recovery. ONS was well‐tolerated, aided EER attendance, and potentially facilitated hospital discharge.